All patient guidesSemua panduan pasien返回全部指南
March 04, 2026 Patient guidePanduan pasien就医指南

Cancer Treatment in Shenzhen: A Guide for International PatientsCancer Treatment in Shenzhen: A Guide for International Patients深圳癌症治疗:国际患者指南

Shenzhen, often dubbed China's Silicon Valley, has rapidly developed into a key destination for cancer treatment, leveraging its innovative spirit and proximity to Hong Kong. In 2026, the city integrates cutting-edge technology with compreh…Shenzhen, often dubbed China's Silicon Valley, has rapidly developed into a key destination for cancer treatment, leveraging its innovative spirit and proximity to Hong Kong. In 2026, the city integrates cutting-edge technology with compreh…深圳,常被称为中国的硅谷,迅速发展成为癌症治疗的关键目的地,利用其创新精神和靠近香港的地理优势。在2026年,这座城市将尖端技术与全面的肿瘤学服务相结合,通过高效的护理、跨境合作和可负担性吸引国际患者。深圳拥有质子治疗中心等设施,并专注于精准医学,为粤港澳大湾区提供高质量的选择。

Shenzhen, often dubbed China's Silicon Valley, has rapidly developed into a key destination for cancer treatment, leveraging its innovative spirit and proximity to Hong Kong. In 2026, the city integrates cutting-edge technology with comprehensive oncology services, attracting international patients through efficient care, cross-border collaborations, and affordability. With facilities like proton therapy centers and a focus on precision medicine, Shenzhen provides high-quality options in the Guangdong-Hong Kong-Macao Greater Bay Area.

This guide summarizes major hospitals, treatment capabilities, approximate costs for international patients, and essential considerations to aid your planning.

Why International Patients Choose Shenzhen for Cancer Care

Shenzhen's oncology landscape offers compelling benefits:

  • Rapid Access and Efficiency: Known for "Shenzhen speed," hospitals provide quick consultations, diagnostics, and treatments—often within days—reducing wait times compared to many global systems.
  • Cost Advantages: Treatments are 30-60% less expensive than in the US or Europe, with outcomes aligned to international standards, supported by high patient volumes and research.
  • Innovation and Technology: As a tech hub, Shenzhen excels in AI-driven diagnostics, robotic surgery, and emerging therapies like CAR-T, often through clinical trials.
  • Cross-Border Convenience: Proximity to Hong Kong enables seamless medical record sharing, access to additional drugs, and easy travel via high-speed rail.
  • International Services: Many hospitals feature multilingual teams (English, Japanese, Korean), direct insurance billing (e.g., Cigna, Allianz), and visa support, making it accessible for foreigners from Southeast Asia and beyond.

Patients frequently select Shenzhen for second opinions, advanced-stage care, or when seeking integrated Western and Traditional Chinese Medicine (TCM) approaches.

Leading Oncology Hospitals in Shenzhen

Shenzhen's hospitals combine national research centers with international collaborations.

  • Cancer Hospital, Chinese Academy of Medical Sciences Shenzhen Center: The southern branch of China's top national cancer institute, specializing in precision medicine for lung, breast, gastrointestinal, and urological cancers. It leads in clinical trials and features a proton therapy center.

  • University of Hong Kong-Shenzhen Hospital (HKU-Shenzhen): Operates under Hong Kong management standards, excelling in multidisciplinary oncology for colorectal, liver, and pancreatic cancers. Its International Medical Center offers English-speaking services and Western-style care.

  • Peking University Shenzhen Hospital: Focuses on thoracic oncology, minimally invasive surgery, and immunotherapy for lung and esophageal cancers, with strong research ties.

  • Southern University of Science and Technology Hospital: Emphasizes innovative therapies like CAR-T and AI-assisted diagnostics, particularly for hematologic and solid tumors.

  • Shenzhen People's Hospital: Provides comprehensive care in radiation oncology and surgical interventions for head/neck and gynecological cancers.

  • Private and International-Focused Options:

  • Shenzhen Nanshan Hospital: Known for integrative TCM-oncology and minimally invasive procedures.
  • Shenzhen Bao'an People's Hospital: Offers advanced radiotherapy and supportive care for elderly patients.
  • Shenzhen University General Hospital: Specializes in precision radiotherapy and molecular targeted therapies.

Public hospitals prioritize research and volume, while those with international ties emphasize patient comfort and language support.

Key Treatment Capabilities

Shenzhen's facilities deliver multidisciplinary, tech-forward care:

  • Multidisciplinary Teams (MDT): Collaborative approaches with surgeons, oncologists, radiologists, and geneticists for tailored plans.
  • Precision Diagnostics: NGS gene sequencing, molecular testing, and AI pathology for targeted matching in lung, breast, and colorectal cancers.
  • Surgery: Robotic (Da Vinci), minimally invasive (laparoscopic), and interventional techniques for faster recovery.
  • Chemotherapy & Targeted Therapy: Affordable domestic options with "chemo-free" regimens.
  • Immunotherapy: PD-1/PD-L1 inhibitors and combinations for advanced cases.
  • Advanced Radiotherapy: IMRT, SBRT, and proton therapy—precise for tumors near vital organs like brain or prostate.
  • CAR-T Cell Therapy: Available for blood cancers and emerging solid tumors, with high remission rates in trials.
  • Integrative TCM: Acupuncture, herbs, and hyperthermia to reduce side effects and enhance immunity.
  • Clinical Trials: Extensive multi-center studies providing free access to novel therapies.

The city's innovation focus ensures expertise in complex and tech-integrated treatments.

Estimated Costs for International Patients (USD, 2026)

Costs vary by hospital, stage, and specifics; international patients typically pay upfront but can use global insurance. Estimates are for private/international departments:

  • Initial Evaluation & Diagnostics: $1,500–$5,000 (consults, PET-CT, biopsies, genetic testing).
  • Surgery: $5,000–$25,000 (standard to robotic/complex).
  • Chemotherapy: $500–$3,000 per cycle; full course $5,000–$15,000.
  • Radiotherapy: $5,000–$12,000 (standard); $10,000–$20,000 (advanced); proton full course $30,000–$50,000.
  • Targeted/Immunotherapy: Monthly $2,000–$6,000; annual $20,000–$50,000.
  • CAR-T Therapy: $50,000–$100,000 (lower in trials).
  • Overall by Stage:
  • Early-stage (surgery + adjuvant): $7,000–$18,000.
  • Mid-stage comprehensive: $18,000–$35,000.
  • Advanced/maintenance (annual): $8,000–$20,000+.

Hospital stays: $20–$100/day (standard); $150–$400/day (VIP). Living costs: $50–$150/night (hotel); $800–$2,000/month (apartment). Clinical trials and insurance can lower expenses.

Practical Advice for Foreign Patients

  • Gather and translate medical records (pathology, scans, history) for virtual reviews.
  • Obtain a medical (S2) visa with hospital invitations.
  • Choose facilities with international centers for multilingual support and billing.
  • Budget for deposits, translation, and cross-border travel if needed.
  • Consider trials for innovative, cost-effective options.
  • Utilize telemedicine for follow-ups.

Shenzhen offers modern, innovative cancer care with strategic advantages for international access. Verify with hospitals for personalized guidance. Best wishes for your recovery.

Shenzhen, often dubbed China's Silicon Valley, has rapidly developed into a key destination for cancer treatment, leveraging its innovative spirit and proximity to Hong Kong. In 2026, the city integrates cutting-edge technology with comprehensive oncology services, attracting international patients through efficient care, cross-border collaborations, and affordability. With facilities like proton therapy centers and a focus on precision medicine, Shenzhen provides high-quality options in the Guangdong-Hong Kong-Macao Greater Bay Area.

This guide summarizes major hospitals, treatment capabilities, approximate costs for international patients, and essential considerations to aid your planning.

Why International Patients Choose Shenzhen for Cancer Care

Shenzhen's oncology landscape offers compelling benefits:

  • Rapid Access and Efficiency: Known for "Shenzhen speed," hospitals provide quick consultations, diagnostics, and treatments—often within days—reducing wait times compared to many global systems.
  • Cost Advantages: Treatments are 30-60% less expensive than in the US or Europe, with outcomes aligned to international standards, supported by high patient volumes and research.
  • Innovation and Technology: As a tech hub, Shenzhen excels in AI-driven diagnostics, robotic surgery, and emerging therapies like CAR-T, often through clinical trials.
  • Cross-Border Convenience: Proximity to Hong Kong enables seamless medical record sharing, access to additional drugs, and easy travel via high-speed rail.
  • International Services: Many hospitals feature multilingual teams (English, Japanese, Korean), direct insurance billing (e.g., Cigna, Allianz), and visa support, making it accessible for foreigners from Southeast Asia and beyond.

Patients frequently select Shenzhen for second opinions, advanced-stage care, or when seeking integrated Western and Traditional Chinese Medicine (TCM) approaches.

Leading Oncology Hospitals in Shenzhen

Shenzhen's hospitals combine national research centers with international collaborations.

  • Cancer Hospital, Chinese Academy of Medical Sciences Shenzhen Center: The southern branch of China's top national cancer institute, specializing in precision medicine for lung, breast, gastrointestinal, and urological cancers. It leads in clinical trials and features a proton therapy center.

  • University of Hong Kong-Shenzhen Hospital (HKU-Shenzhen): Operates under Hong Kong management standards, excelling in multidisciplinary oncology for colorectal, liver, and pancreatic cancers. Its International Medical Center offers English-speaking services and Western-style care.

  • Peking University Shenzhen Hospital: Focuses on thoracic oncology, minimally invasive surgery, and immunotherapy for lung and esophageal cancers, with strong research ties.

  • Southern University of Science and Technology Hospital: Emphasizes innovative therapies like CAR-T and AI-assisted diagnostics, particularly for hematologic and solid tumors.

  • Shenzhen People's Hospital: Provides comprehensive care in radiation oncology and surgical interventions for head/neck and gynecological cancers.

  • Private and International-Focused Options:

  • Shenzhen Nanshan Hospital: Known for integrative TCM-oncology and minimally invasive procedures.
  • Shenzhen Bao'an People's Hospital: Offers advanced radiotherapy and supportive care for elderly patients.
  • Shenzhen University General Hospital: Specializes in precision radiotherapy and molecular targeted therapies.

Public hospitals prioritize research and volume, while those with international ties emphasize patient comfort and language support.

Key Treatment Capabilities

Shenzhen's facilities deliver multidisciplinary, tech-forward care:

  • Multidisciplinary Teams (MDT): Collaborative approaches with surgeons, oncologists, radiologists, and geneticists for tailored plans.
  • Precision Diagnostics: NGS gene sequencing, molecular testing, and AI pathology for targeted matching in lung, breast, and colorectal cancers.
  • Surgery: Robotic (Da Vinci), minimally invasive (laparoscopic), and interventional techniques for faster recovery.
  • Chemotherapy & Targeted Therapy: Affordable domestic options with "chemo-free" regimens.
  • Immunotherapy: PD-1/PD-L1 inhibitors and combinations for advanced cases.
  • Advanced Radiotherapy: IMRT, SBRT, and proton therapy—precise for tumors near vital organs like brain or prostate.
  • CAR-T Cell Therapy: Available for blood cancers and emerging solid tumors, with high remission rates in trials.
  • Integrative TCM: Acupuncture, herbs, and hyperthermia to reduce side effects and enhance immunity.
  • Clinical Trials: Extensive multi-center studies providing free access to novel therapies.

The city's innovation focus ensures expertise in complex and tech-integrated treatments.

Estimated Costs for International Patients (USD, 2026)

Costs vary by hospital, stage, and specifics; international patients typically pay upfront but can use global insurance. Estimates are for private/international departments:

  • Initial Evaluation & Diagnostics: $1,500–$5,000 (consults, PET-CT, biopsies, genetic testing).
  • Surgery: $5,000–$25,000 (standard to robotic/complex).
  • Chemotherapy: $500–$3,000 per cycle; full course $5,000–$15,000.
  • Radiotherapy: $5,000–$12,000 (standard); $10,000–$20,000 (advanced); proton full course $30,000–$50,000.
  • Targeted/Immunotherapy: Monthly $2,000–$6,000; annual $20,000–$50,000.
  • CAR-T Therapy: $50,000–$100,000 (lower in trials).
  • Overall by Stage:
  • Early-stage (surgery + adjuvant): $7,000–$18,000.
  • Mid-stage comprehensive: $18,000–$35,000.
  • Advanced/maintenance (annual): $8,000–$20,000+.

Hospital stays: $20–$100/day (standard); $150–$400/day (VIP). Living costs: $50–$150/night (hotel); $800–$2,000/month (apartment). Clinical trials and insurance can lower expenses.

Practical Advice for Foreign Patients

  • Gather and translate medical records (pathology, scans, history) for virtual reviews.
  • Obtain a medical (S2) visa with hospital invitations.
  • Choose facilities with international centers for multilingual support and billing.
  • Budget for deposits, translation, and cross-border travel if needed.
  • Consider trials for innovative, cost-effective options.
  • Utilize telemedicine for follow-ups.

Shenzhen offers modern, innovative cancer care with strategic advantages for international access. Verify with hospitals for personalized guidance. Best wishes for your recovery.

深圳,常被称为中国的硅谷,迅速发展成为癌症治疗的关键目的地,利用其创新精神和靠近香港的地理优势。在2026年,这座城市将尖端技术与全面的肿瘤学服务相结合,通过高效的护理、跨境合作和可负担性吸引国际患者。深圳拥有质子治疗中心等设施,并专注于精准医学,为粤港澳大湾区提供高质量的选择。

本指南总结了主要医院、治疗能力、国际患者的近似费用以及重要考虑事项,以帮助您的规划。

为什么国际患者选择深圳进行癌症护理

深圳的肿瘤学领域提供了令人信服的优势:

  • 快速访问和效率:以“深圳速度”闻名,医院提供快速的咨询、诊断和治疗——通常在几天内——减少了与许多全球系统相比的等待时间。
  • 成本优势:治疗费用比美国或欧洲低30-60%,疗效符合国际标准,得益于高患者量和研究支持。
  • 创新和技术:作为科技中心,深圳在人工智能驱动的诊断、机器人手术和新兴疗法(如CAR-T)方面表现出色,通常通过临床试验进行。
  • 跨境便利:靠近香港使得医疗记录共享、获取额外药物和通过高铁轻松旅行成为可能。
  • 国际服务:许多医院设有多语言团队(英语、日语、韩语)、直接保险结算(如Cigna、安联)和签证支持,使来自东南亚及其他地区的外国人更易于接受治疗。

患者经常选择深圳进行第二意见、晚期护理,或寻求西方与传统中医(TCM)相结合的方法。

深圳领先的肿瘤医院

深圳的医院将国家研究中心与国际合作相结合。

  • 中国医学科学院深圳癌症医院:中国顶级国家癌症研究所的南方分支,专注于肺癌、乳腺癌、胃肠癌和泌尿系统癌症的精准医学。它在临床试验方面处于领先地位,并设有质子治疗中心。

  • 香港大学深圳医院(HKU-深圳):在香港管理标准下运营,在结直肠癌、肝癌和胰腺癌的多学科肿瘤学方面表现出色。其国际医疗中心提供英语服务和西式护理。

  • 北京大学深圳医院:专注于胸部肿瘤学、微创手术和肺癌及食管癌的免疫治疗,具有强大的研究联系。

  • 南方科技大学医院:强调创新疗法,如CAR-T和人工智能辅助诊断,特别是针对血液肿瘤和实体肿瘤。

  • 深圳人民医院:提供全面的放射肿瘤学护理和头颈癌及妇科癌症的外科干预。

  • 私人和国际化选项:

  • 深圳南山医院:以综合中西医结合和微创手术而闻名。
  • 深圳宝安人民医院:为老年患者提供先进的放疗和支持性护理。
  • 深圳大学总医院:专注于精准放疗和分子靶向治疗。

公立医院优先考虑研究和患者量,而与国际有联系的医院则强调患者舒适度和语言支持。

主要治疗能力

深圳的设施提供多学科、技术前沿的护理:

  • 多学科团队(MDT):外科医生、肿瘤学家、放射科医生和遗传学家协作制定个性化方案。
  • 精准诊断:NGS基因测序、分子检测和人工智能病理学,针对肺癌、乳腺癌和结直肠癌进行靶向匹配。
  • 手术:机器人手术(达芬奇)、微创手术(腹腔镜)和介入技术,促进更快的恢复。
  • 化疗和靶向治疗:提供经济实惠的国内选择,包含“无化疗”方案。
  • 免疫治疗:PD-1/PD-L1抑制剂及其组合,适用于晚期病例。
  • 先进放疗:IMRT、SBRT和质子治疗——对靠近重要器官(如大脑或前列腺)的肿瘤进行精准治疗。
  • CAR-T细胞治疗:适用于血液癌症和新兴实体肿瘤,临床试验中的缓解率高。
  • 综合中医:针灸、草药和热疗以减少副作用并增强免疫力。
  • 临床试验:广泛的多中心研究提供免费接触新疗法的机会。

该市的创新重点确保在复杂和技术整合治疗方面的专业知识。

国际患者的预估费用(美元,2026年)

费用因医院、阶段和具体情况而异;国际患者通常需预付费用,但可以使用全球保险。以下是私人/国际部门的估算:

  • 初步评估和诊断:$1,500–$5,000(咨询、PET-CT、活检、基因检测)。
  • 手术:$5,000–$25,000(标准到机器人/复杂)。
  • 化疗:每周期$500–$3,000;完整疗程$5,000–$15,000。
  • 放疗:$5,000–$12,000(标准);$10,000–$20,000(先进);质子完整疗程$30,000–$50,000。
  • 靶向/免疫治疗:每月$2,000–$6,000;每年$20,000–$50,000。
  • CAR-T治疗:$50,000–$100,000(临床试验中费用更低)。
  • 按阶段的整体费用:
  • 早期阶段(手术+辅助治疗):$7,000–$18,000。
  • 中期综合治疗:$18,000–$35,000。
  • 晚期/维持治疗(每年):$8,000–$20,000+。

住院费用:$20–$100/天(标准);$150–$400/天(VIP)。生活费用:$50–$150/晚(酒店);$800–$2,000/月(公寓)。临床试验和保险可以降低费用。

外国患者的实用建议

  • 收集并翻译医疗记录(病理、扫描、历史)以便进行虚拟评审。
  • 获取医院邀请的医疗(S2)签证。
  • 选择设有国际中心的设施,以获得多语言支持和结算服务。
  • 预算存款、翻译和必要的跨境旅行费用。
  • 考虑参与临床试验以获取创新且经济实惠的选择。
  • 利用远程医疗进行后续随访。

深圳提供现代、创新的癌症护理,为国际患者提供战略优势。请与医院核实以获取个性化指导。祝您早日康复。

WhatsApp